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T follicular helper (Tfh) cells have been thrust into the limelight since the recent discovery of their unique
developmental program. Exciting new insights into the regulation of Tfh development, migration, and func-
tion were presented at the first Gordon Conference on Tfh cells held in Hong Kong and summarized here.Figure 1. Although tranquil mountains emerging from the parting
fog might not be an image one associates with the hustle and bustle
of Hong Kong, it is indicative of the clarity on many aspects of Tfh
cell biology that became apparent from this first GRCmeeting on Tfh
cells.Ever-vibrant Hong Kong (Figure 1) hosted the first Gordon con-
ference on T follicular helper (Tfh) cells, the subset of CD4+
T cells that specializes in providing help to B cells in the germinal
centers, at the Chinese University of Hong Kong located at New
Territory on July 21–24, 2013. More than 35 speakers brought
considerable excitement and diversity to the meeting. It was
timely because discoveries in the field have grown exponentially
in the last few years, and virtually every talk presented new and
unpublished advances in the field, giving rise to in-depth and
illuminating discussions. The meeting opened with an excep-
tional lecture by Max D. Cooper who, by presenting an evolu-
tionary perspective on the development of acquired immunity,
offered the perfect setting for discussing the fine-tuned and
multilayered regulation of T and B lymphocyte subsets in
vertebrates. Here we review the most notable conceptual devel-
opments in the field originating from the meeting.
Tfh Cell Development
Evidence was presented for selective roles of different antigen-
presenting cells (APCs) in Tfh cell development. It appears that
the adjuvant used might largely determine the type of APC
required to induce Tfh cell differentiation. For example,
Madelene Dahlgren presented evidence that CD11c+ dendritic
cells (DCs) are not needed when poly:IC is used as an adjuvant.
Hideki Ueno discussed how, in humans, only T cells cultured
with CD14+ dermal DCs, but not Langherhans cells, can produce
interleukin-12 (IL-12) and become IL-21-producing Tfh-like cells
capable of helping B cells. Pamela Schwartzberg discussed how
the adaptor protein SAP regulates positive and negative signals
from SLAM family receptors that affect early T cell activation and
finely tunes the interactions of T and B cells required for germinal
center Tfh cells and CD8+ T cell killing of B cell targets.
The transcription landscape of Tfh cells is also becoming
clearer. Chen Dong revealed that a pathway independent of
Bcl6 might be critical for the initial upregulation of CXCR5
triggered by T cell receptor (TCR) signaling, prior to Bcl6 induc-
tion. Bcl6 does not bind directly the Cxcr5 promoter, thus other
factors might be important in CXCR5 regulation and T cell migra-
tion to follicles. Other roles for transcription factors acting
upstream of Bcl6 were also described by Shane Crotty: the ubiq-
uitin ligase Itch appears critical for Bcl6 upregulation, achieved
indirectly via ubiquitination-dependent degradation of the tran-
scription factor Foxo1, which represses Bcl6 transcription.
Itch/ mice lack Tfh cells, yet their development is rescuedwhen Foxo1 deficiency is introduced into the mice. In contrast,
mice deficient in the ubiquitin ligase Grail developed exacer-
bated germinal center reactions, the underlying mechanism of
which is under investigation by Roza Nurieva and her laboratory.
Masato Kubo presented data that Tfh cells also use other tran-
scription factors including Notch and GATA-3 to regulate their
expression of IL-4. T-bet, although apparently promoting Tfh
cell migration into follicles by upregulating CXCR5 and blocking
CCR7 and EBI2 expression, noted Hideki Ueno, negatively reg-
ulates Tfh cell function by reducing ICOS, CD40L, and IL-21
expression.
Posttranscriptional regulation of Tfh cells was also discussed,
with novel contributors emerging, both in terms of miRNAs and
RNA-binding proteins. The microRNA cluster miR-17-92 and
its two paralog clusters are required for Tfh cell formation, their
migration into the follicles, and Tfh cell identity. Changchun
Xiao and Lukas Jeker noted that these diverse functions are
achieved through targeting of a number of messenger RNAs
(mRNAs) including those encoding PTEN, which regulates PIP2
to PIP3 conversion; PHLPP2 that controls AKT activationImmunity 39, September 19, 2013 ª2013 Elsevier Inc. 417
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that induces CCR6 and other genes associated with T helper 17
(Th17) or Th22 cells. A member of the Roquin RNA-regulating
family was also discussed by Vigo Heissmeyer and Carola
Vinuesa: Roquin-2 appears to compensate for the role of
Roquin-1 in ICOS and OX40 mRNA repression and only the
double deficiency leads to the Tfh cell accumulation phenotype
observed in mice homozygous for the ‘‘san’’ niche-filling allele of
Roquin.
Data presented at the meeting finally reconciled conflicting re-
ports about the T cell-intrinsic versus extrinsic roles of IL-21 in
promoting Tfh cell development. Cecile King presented evidence
that the ability to distinguish true Tfh cells (helper) versus their
regulatory counterpart derived from FoxP3+ T cells—Tfr cells—
might finally put a nail in the coffin of the theories that IL-21
does not signal in T cells to promote Tfh cells: When FoxP3 is
used to separate Tfh (FoxP3) versus Tfr (FoxP3+) cells that
otherwise share the follicular phenotype—CXCR5hiPD-
1hiBcl6+—it becomes clear that IL-21 promotes survival of Ag-
specific Tfh cells, and in the absence of IL-21 there are reduced
Tfh cells and expanded Tfr cells. The latter is consistent with the
previously demonstrated expansion of FoxP3+ T cells in IL-21-
deficient mice and the known effects of IL-21 in inhibiting T cell
production of IL-2 leading to decreased FoxP3 expression and
impaired maintenance of FoxP3+ T cells. The combination of
IL-27 and IL-6R signals via gp130 in T cells appears to be
important for Tfh cell escalation, IL-21 production, and the
survival of virus-specific CD4+ T cells that enable virus control
at late stages after LCMV chronic infection, noted Elina Zuniga.
Stuart Tangye and Hideki Ueno presented work showing that
in humans, IL-12 appears to be the cytokine that is best capable
to induce IL-21 production. IL-12 signals activate STAT4 that
induces a first wave of IL-21 production, which acts in an
autocrine manner via IL-21R to activate STAT3 and enhance
Tfh cell differentiation, noted Tangye.
Tfh Cell Migration and Localization
Although much progress has been made in understanding the
cues that control B cell migration in and out of the different com-
partments in secondary lymphoid organs, including germinal
centers, little is known regarding the key determinants of Tfh
cell migration, persistence and exit from germinal centers,
besides the role of CXCR5. But this is rapidly changing with
the description of roles for ICOS, GPCR and integrins in follicular
migration and retention within germinal centers. Hai Qi pre-
sented that ICOS is required for coordinated and persistent
T cell motility at the T-B cell border in response to ICOSL
expressed by follicular B cells; together with CXCR5, it drives
T cell relocation into the follicle. Takaharu Okada presented
work showing that a GPCRmainly expressed in Tfh cells located
within germinal centers was found to be required for optimal
localization within GCs. Although T cells deficient in this factor
can support normal magnitudes of GC development, there
appears to be some redundancy with CXCR5 because double
deficiency in the GPCR and CXCR5 cause impaired GC forma-
tion and antibody responses. L-integrins also appear to play a
role in the retention of Tfh cells, and this is probably mediated
by ICAM-1 or ICAM-2 interactions with LFA-1; IL-4-producing
Tfh cells express a highly active form of LFA-1 and appear to418 Immunity 39, September 19, 2013 ª2013 Elsevier Inc.bind ICAM-1 more strongly than other T cells, showed Irah
King. The precise ICAM isoform and cellular source remains to
be elucidated. Joe Craft discussed the role of P-selectin glyco-
protein ligand-1 in T cell migration to B cell follicles and its utility
as a marker of Tfh cell subset differentiation. In the contraction
phase, Tfh cells survived as central memory T cells after a
dynamic localization change mediated by reciprocal changes
in expression of CCR7 (increased) and CXCR5 (decreased),
moving to the T-B border area. Memory Tfh cells reentered the
GCs, noted Masato Kubo, promoting antibody responses in a
recall response.
Regulatory T Cells Controlling Tfh Cells: New Cells and
New Functions
Following the study describing a role for PD-1 in limiting Tfh cells
and controlling gut microbiota to prevent dysbiosis (Kawamoto
et al., 2012), new data were presented by Sidonia Fagarasan
demonstrating that Foxp3+ T cells, by preventing expansion of
Foxp3 T cells and by regulating the selection of immunoglobulin
As (IgAs) after their differentiation into Tfr and Tfh cells in
germinal centers of Peyer’s patches, control bacterial commu-
nities in the gut. Besides Tfr cells, Mi-Na Kweon presented
data that Toll-like receptor signals in the gut also prevent Tfh
cell expansion and the emergence of autoantibodies to Salmo-
nella: Myd88/ mice developed increased Tfh cells and GCs,
hypergammaglobulinemia, and autoantibodies in response to
oral attenuated Salmonella vaccine, and this was ameliorated
by blockade of PD-1 and ICOS. Evidence for more pronounced
defects in Th1 than Tfh cell responses in the absence of Raptor-
mTOR signaling was presented by Lilin Ye, together with data
demonstrating that mTOR-mediated regulation of germinal cen-
ter responses acting B cell autonomously. Finally, Arlene Sharpe
showed beautiful data of blood-circulating Tfr cells, which are
also negatively regulated by PD-1 signaling.
Other FoxP3 T cells controlling Tfh cells in germinal centers
were also discussed. Qa-1 restricted CD8+ T cells previously
shown to repress Tfh cells in a perforin and IL-15-dependent
manner have more recently been shown to be dependent on
the transcription factor HELIOS, noted Harvey Cantor. And yet
another type of regulatory T cells - IL-10 producing Tr1 cells in
liver generated in response to Kupfer cell-derived IL-10, induce
liver tolerance in HBV carrier mice. Hepatic Tr1 cells were shown
by Zhigang Tian tomigrate to draining LNs and inactivate Tfh and
GC. Anti-IL10R antibody could rescue GC formation although
the effect on Tfh numbers was modest.
New Insights into Germinal Center Function and
Regulation
Germinal centers are one of the least well-understood processes
in immunology, with many of the fundamental questions remain-
ing unanswered. Now, by using a combination of old and new
approaches, some groups are providing intriguing answers.
Some of these questions include:
Is compartmentalization of GCB cells into dark zones (DZ) and
light zones (LZ) required for optimal antibody responses? The
answer appears to be yes. B cells lacking CXCR4 can still give
rise to cells with DZ and LZ phenotypes, but they no longer
distribute into two separate compartments, showed Jason
Cyster; rather, they are intermixed within the entire GC. Although
Immunity
Meeting Reportproliferation and survival do not appear to be affected, the
cells acquire fewer mutations indicative of reduced affinity
maturation, and memory formation appears accelerated, sug-
gesting early exit from GCs. Cyster’s interpretation is that
sequestration of GC B cells in dark zones devoid of T cells
might protect them from T cell selection signals and allow
increased rounds of division and mutation between selection
cycles.
Are GCs important in removing self-reactivity? The answer is
yes. Christopher Goodnow showed that in a transgenic mouse
model, self-reactive IgD+ cells are readily recruited into GCs
where they are redeemed from self-reactivity through the acqui-
sition of mutations that remove reactivity for the self-component
of the immunizing antigen, but not for foreign epitopes.
How is tolerance enforced in the face of B cells acquiring
mutations that increase cross-reactivity with self? Elegant
recent work suggests that there is differential enforcement of
tolerance according to the amounts of self-antigen and the
distance to the self-antigen-source. Low concentrations of
self-antigen and expression of self-antigen only in distal tissues
have no effect in preventing selection of self-reactive specific-
ities. In contrast, Robert Brink presented work showing that
high concentrations of self-antigen and expression of this
self-antigen in the lymph node tissue lead to effective elimina-
tion of self-reactive B cells that arise in the process of somatic
hypermutation.
What is the role of secondary GCs? Intensive single-cell geno-
mics combined with large-scale single cell phenomics are finally
allowing following the fate of individual B cells and inferring the
behaviors of individual members within these clones; this
approach is beginning to shed light on the composition and func-
tion of GCs during recall responses, noted Michael McHeyzer
Williams.
Does antibody contribute to affinity maturation? An antibody
feedback-based model has been proposed by the demonstra-
tion that antibody can move into and regulate established GCs
if the antibody affinity is sufficiently high, to promote production
of even higher affinity antibody. High-antibody affinity led to
increased apoptosis in GC and lower plasmablast output. This
model suggests that antibodies generate a systemic selection
threshold and promote competition between different GCs. B
cells would then produce their own adequate directional pres-
sure to accelerate affinity maturation. This antibody feedback
can in principle also terminate the GC reaction, showed
Kai-Michael Toellner.
Tfh Cells in Human Health
The use of additional markers to refining human circulating Tfh-
like subsets has proven very valuable in identifying the best
blood correlates of germinal center Tfh cells or an active Tfh
effector program. In HIV-infected individuals, circulating
PD-1+CXCR3CXCR5+CD4+ memory T cells are related with
GC Tfh cells and are the most capable in helping
memory B cells. In HIV+ individuals, these circulating PD-
1+CXCR3CXCR5+CD4+ T cells correlate with broadly neutral-
izing HIV antibody producers, revealed Shane Crotty. This is in
contrast to studies in influenza vaccination, where CXCR3+
ICOS+PD-1+CXCR5+ cells are themost efficient helpers ofmem-
ory B cells, and correlate with antibody responses [H. Ueno].Therefore, the type of Tfh cells primarily associated with anti-
body responses appears to differ according to the context. In
active SLE and RA, increased CCR7loPD-1hiCXCR5+ cells corre-
late with disease activity and reflect an active Tfh cell program [Di
Yu]. Of interest, these circulating Tfh cells appear to be gener-
ated from pre-Tfh cells that have not yet entered GCs, in a
SAP-independent but ICOS and BCL6-dependent manner, and
can induce Tfh cell responses in draining and distal LN upon
transfer. Stuart Tangye noted that circulating CXCR5+ cells are
decreased in patients with loss-of-function mutations in genes
that encode CD40L, NEMO, STAT3, IL-21R and BTK and in
patients with gain-of-function mutations in genes that encode
STAT1. Of all circulating CXCR5+ Tfh cells, it is the Th17 cell-
like subset—CCR6+CXCR3 (Morita et al., 2011)—that is most
reduced with all deficiencies above, again suggesting these
are the dominant B cell helpers. Hideki Ueno noted that
IL-12R-deficient children have very low frequency of blood Tfh
cells.
Finally, it has been recently shown that human Tfh-like cells
are particularly sensitive to mutations in isocitrate dehydroge-
nase 2 (IDH2) R172, which normally converts isocitrate to
a-ketoglutarate, generating NADPH. When IDH2 is mutated,
it leads to accumulation of the cancer-associated metabolite
2-hydroxyglutarate (D2-HG). IDH1 or IDH2 is mutated in 80%
of glyomas and 15% acute myeloid leukemia. Strikingly,
IDH2 R172 is mutated in 20%–40% of Tfh cell-derived lym-
phomas (angioimmunoblastic lymphoma, AITL), but not in
other type of T cell lymphomas (Cairns et al., 2012). D2-HG
is thought to induce changes in reactive oxygen species and
blocks a-ketoglutarate-dependent enzymes, leading to altered
DNA, histone methylation, and cytosine methylation. Of note,
preliminary data by Tak Mak suggest that a mouse in which
the IDH1 R132H mutation was knocked in by Vav-Cre has
developed a T cell lymphoma that has the features of
AITL and can induce aggressive tumors within 8 weeks after
transplant.
Perspectives
The conference provided an ideal forum for discussion on the
identity and function of Tfh cells. Two key issues were discussed
in some depth that required some consensus in terms of meth-
odology and/or nomenclature:
1. The need to differentiate between Tfr cells and Tfh cells.
Tfh and Tfr cells share expression of CXCR5, ICOS, PD-1,
and Bcl6 but differ functionally: Tfh cells lack Foxp3 expression
and are efficient B cell helpers, whereas Tfr cells coexpress
Foxp3 and exert a repressive function. It is critical to add
Foxp3 expression to distinguish Tfh from Tfr cells in future
studies so that one can more easily reconcile otherwise appar-
ently contradictory findings regarding the consequences of
numerical changes in these populations on GC B cell biology
and autoimmune processes.
2. The importance of studying circulating Tfh-like cells to
identify the best correlates of effective or excessive or aberrant
B cell help in the context of vaccination and autoimmunity: It is
clear that circulating CD4+ T cells that might not have Bcl6
expression and extrafollicular T cells are capable of providing
help to B cells; it is likely that most B cell helper T cells share
parts of the developmental program of those Tfh cells in GCs.Immunity 39, September 19, 2013 ª2013 Elsevier Inc. 419
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markers such as PD-1, CXCR3, and CCR7, as well as subset-
specific transcription factors, greatly enhance the capacity to
identify correlations with high-affinity antibody responses or
systemic autoimmunity as elegantly demonstrated by Yu,
Ueno, and Crotty.
With many remaining basic issues unsolved and important
clinical applications looming in the horizon, the attendees voted
to resume the discussion in the second Tfh GordonConference 2
years from now in beautiful Girona, Spain.420 Immunity 39, September 19, 2013 ª2013 Elsevier Inc.REFERENCES
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